Patent Assignment
Reel/Frame 016039/0044
Assignment of Assignor's Interest
Recorded: 2005-04-08
Pages: 3
Assignor
DIABETOGEN BIOSCIENCES, INC.
Executed: 2005-04-05
Assignee
TOLERRX, INC.
300 TECHNOLOGY SQUARE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Fully human anti-CD3 monoclonal antibodies
Application:
10/383,247 →
Publication:
US 2003/0216551
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.